You are currently viewing a new version of our website. To view the old version click .

Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps 2.0

This special issue belongs to the section “Epidemiology and Vaccination“.

Special Issue Information

Dear Colleagues,

Globally, infant and childhood vaccine coverage rates are still not high enough, with outbreaks of vaccine-preventable diseases occurring frequently even in high-income countries. Vaccine hesitancy is one of the factors explaining the suboptimal percentages of vaccination coverage, defined by the SAGE group as a “delay in acceptance or refusal of vaccines despite availability of vaccine services”. The decision not to vaccinate or delay vaccine shots comes from a complex decision-making process influenced by numerous factors related to population, context, environment, historical period, and single vaccine.

This recent worldwide increase in vaccine hesitancy led the World Health Organization to list vaccine hesitancy as one of the top 10 health threats facing the world in 2019. This has led several high-, middle-, and low-income countries to enact, strengthen or contemplate mandatory and/or recommended infant and childhood immunization in order to address this novel gap.

This Special Issue focuses on the knowledge and strategies to reduce vaccine hesitancy and improve vaccination coverage rates in the group of infant and childhood. Submission of original articles, systematic reviews, short communications, and other types of article on related topics is welcome. Manuscripts should follow standard journal peer-review practices, and those accepted for publication will appear in the Special Issue on “Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps”.

Prof. Dr. Davide Gori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Vaccine hesitancy
  • Child immunizations
  • Vaccination coverage rates
  • Interventions and strategies
  • Rationales, issues, and knowledge
  • Vaccine-preventable diseases
  • Adverse events
  • Vaccine uptake

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X